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Abstract
Background: Women are twice as likely to be diagnosed with major depressive disorder (MDD) compared to men,
but the molecular mechanisms underlying this sex difference are unclear. Previous studies in the human
postmortem brain suggest dysfunction in basolateral amygdala (BLA) inhibitory gamma-aminobutyric acid (GABA)
signaling and brain-derived neurotrophic factor (BDNF) function, specifically in females with MDD.
Methods: We investigated the effects of sex chromosome complement, developmental gonadal sex, and
circulating testosterone on expression of 3 GABA-related and 2 BDNF-related genes in the BLA using three cohorts
of four core genotypes (FCG) mice. Cohort 1 included gonadally intact pre-pubertal FCG mice; results were
analyzed using two-way ANOVA (sex chromosome complement-by-gonadal sex). We examined the same genes
under adult non-stressed (cohort 2) and chronically stressed conditions (cohort 3). The results for cohorts 2 and 3
were analyzed by three-way ANOVA (sex chromosome complement-by-gonadal sex-by-hormone). The use of
heatmaps and Spearman correlation of BLA gene expression and anxiety-like behavior provides a global
interpretation of gene expression patterns.
Results: In weanlings, we found an effect of sex chromosome complement, with lower expression of GABA/
BDNF-related genes in XY mice. Most of these effects did not persist into adulthood, although a number of
interesting interactions between organizational and activational effects of hormones emerged. In our adult cohorts,
we found that testosterone had different effects depending on stress conditions and/or gonadal sex. Notably,
in our chronically stressed adults, we found that the BLA pattern of gene expression for the GABA-related gene,
somatostatin (Sst), matched the anxiety-like behavior pattern (i.e., lower Sst and higher anxiety-like behavior in XY
mice, while testosterone increased Sst and decreased anxiety-like behavior). Additionally, increased Sst gene
expression was correlated with decreased anxiety-like behavior.
Conclusions: Sex chromosome complement is an important factor modulating expression of mood-related genes
during pre-pubertal development. The observed sex differences under chronically stressed conditions suggest that
different molecular profiles may characterize male and female MDD. Our findings here for Sst are especially
interesting, and suggest an underlying XY vulnerability that is typically compensated for by circulating testosterone
in “normal” males. Without testosterone, women may have lower SST expression in the amygdala, resulting in
increased MDD vulnerability.
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Background
Major depressive disorder (MDD) is a severe and com-
monly chronic illness characterized by altered mood
regulation that is often accompanied by other psycho-
physiological changes [1]. MDD affects approximately
6.7 % of the US population 18 years or older each year [2],
with women being two times more likely than men to be
diagnosed with the disorder [3, 4]. Additionally, symptom
prevalence also differs between men and women. For in-
stance, women experience more symptoms and have
higher severity of symptoms, along with experiencing
more subjective distress [5–7]. Women are also more
likely to have hyperphagia, hypersomnia, a seasonal effect
on mood, and a comorbid anxiety disorder along with
their depression [8]. These sex differences suggest that
MDD might manifest differently in men and women, with
potentially different underlying biological mechanisms
driving the disorder. As such, it is important to discern
what distinguishes female and male depression in order to
not only better understand MDD in each sex, but MDD
overall. Eventually, by improving this understanding, we
hope to contribute to the goal of developing sex-targeted
treatments for depression.
Previous studies provide evidence of dysfunction across
corticolimbic brain regions in depressed human subjects,
as reviewed in [9, 10]. The corticolimbic circuit is
comprised of the dorsolateral prefrontal cortex (DLPFC;
an important mood regulation and decision-making brain
area), the amygdala (known commonly as the “fear”
center), the hippocampus (the memory center), and the
subgenual anterior cingulate cortex (sgACC; important
for modulation of emotional responses). The DLPFC com-
municates with the amygdala through the sgACC [11, 12].
As a hub in the corticolimbic network of affect regulation,
the amygdala processes emotionally salient stimuli and, in
concert with cortical feedback, initiates a behavioral
response [13]. Studies using fMRI neuroimaging show that
MDD patients exhibit abnormal processing of emotional
stimuli, with increased and prolonged amygdala activity in
response to a variety of negative stimuli [14, 15] (although
[16, 17]). Similarly, amygdala hyperactivity is reported in
patients with various anxiety disorders, including post-
traumatic stress, generalized anxiety, and social anxiety
disorders [18].
Within the corticolimbic circuit, several studies sug-
gest dysfunction in inhibitory gamma-aminobutyric acid
(GABA) signaling in MDD. GABA is a key inhibitory
neurotransmitter present in each node of the corticolim-
bic circuit. Studies suggest that decreased GABA inhib-
ition in the circuit contributes to impaired excitation/
inhibition balance in mood disorders [19, 20]. Somato-
statin (SST), a marker of a subtype of GABA interneu-
rons that preferentially target the distal dendrites of
excitatory pyramidal cells, is more robustly reduced in
female subjects with depression [21]. Interestingly, while
SST is reduced in the sgACC of both men and women
with depression, this SST reduction in the amygdala is
specific to females, strongly suggesting important poten-
tial sex differences in the amygdala of depressed subjects
[22]. In addition to the reduction in SST in depression,
there is also a deficit in expression of the GABA-
synthesizing enzymes glutamate decarboxylase 1 (GAD1,
also known as GAD67) and GAD2 (also known as
GAD65). Additionally, we previously found tight co-
expression of SST, GAD67, and GAD65 in the human
postmortem brain, suggesting shared function and/or up-
stream regulators [22]. Taken together, this suggests sig-
nificant disruption of GABA regulation in subjects with
MDD that is specific to females in the amygdala. Brain-
derived neurotrophic factor (BDNF), which is important
for growth and survival of neurons in the brain, is also af-
fected in MDD [23]. Previously, the patterns of gene ex-
pression indicate a robust decrease in BDNF signaling in
depressed subjects (both sexes in the sgACC and females
only in the amygdala [23, 24]). TrkB, the BDNF receptor, is
also reduced in subjects with MDD [24]. In the amygdala,
only females with MDD had a reduction in BDNF expres-
sion, suggesting that there may be an underlying difference
in BDNF-related signaling in the amygdala due to a sex-
related factor(s).
We are especially interested in investigating the under-
lying sex-specific mechanisms that drive the observed
sex differences in humans. There are three categories of
sex differences we investigate: (1) the effects of sex
chromosome complement (driven by XX vs. XY); (2) the
effects of developmental gonadal hormones (termed
organizational effects of hormones; considered perman-
ent); and (3) the effects of adult circulating hormones
(termed activational effects of hormones; considered
transient) [25, 26]. While we have observed many sex
differences in humans, there are several issues that arise
when it comes to identifying clear sex dependent mecha-
nisms underlying these observed human sex differences.
First, since sex chromosome complement determines
gonadal sex in humans, it is impossible to determine
whether observed sex differences are driven by one sex-
specific factor over the other. Additionally, we do not
know the circulating hormone levels at the time of death
for our human postmortem subjects, or how those levels
might have varied during human subjects’ lifetimes. These
limitations make it difficult to identify specifically which
sex-related variables are driving any of the previously
observed sex differences in subjects with MDD. With
these limitations on human studies, we are motivated to
move our studies to mouse models, where we can more
tightly control different sex-related factors and more easily
manipulate our system of interest [27]. Since the structure
of the corticolimbic network in mice is comparable to that
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of humans, we can study the analogous brain regions in
mice as a model for expanding our understanding of the
overall circuit.
It is still difficult to discern the three major types of sex
differences in typical wild-type mice, as sex chromosome
complement still drives gonadal sex. However, we can take
advantage of genetically modified strains of mice, such as
the four core genotypes (FCG) mice, where sex chromo-
some complement and gonadal sex are decoupled. By
crossing a C57BL/6J female mouse with a XY−Sry (XYM)
male (where the testes-determining gene, Sry, is located as
an autosomal transgene as opposed to being located on
the Y chromosome), we can generate four different geno-
types in which sex chromosome complement is no longer
tied to gonadal sex [XXF (genetic and gonadal female),
XYF (genetic male, gonadal female), XXM (genetic female,
gonadal male), and XYM (genetic and gonadal male)].
This allows us to independently analyze the effects of sex
chromosome complement and gonadal sex, and better
determine which component is responsible for observed
sex differences. Moreover, we can manipulate adult circu-
lating hormone levels to examine the activational effects
of hormones as well.
In our previous studies examining behavior in chronic-
ally stressed FCG mice, we found a decrease in anxiety-
like behavior with adult testosterone treatment, as was
expected given previous evidence for reduced anxiety with
testosterone [28]. However, we also observed a surprising
effect of sex chromosome complement, with XY mice
having higher anxiety-like behavior compared to XX mice
[22]. This was surprising given the higher female preva-
lence of mood disorders. This led us to speculate that, in a
normal male, adult circulating testosterone may override
the underlying vulnerability to increased anxiety-like be-
haviors caused by male sex chromosome complement. It
was through the use of FCG mice that the underlying vul-
nerability in genetic males could be revealed. We were
then interested in determining the molecular mechanisms
underlying these observed effects on anxiety-like behavior
in stressed mice. We began by investigating genes in the
frontal cortex as a putative mouse homologue of the
sgACC which we have studied in humans with MDD. We
found that chronically stressed XY mice had lower expres-
sion of Sst, Gad67, Gad65, and TrkB compared to chron-
ically stressed XX mice; this gene expression result is
completely consistent with XY mice having higher
anxiety-like behavior. Additionally, testosterone treatment
resulted in reduced frontal cortex Bdnf expression, but
only in gonadal females [22]. While informative, our find-
ings in the frontal cortex of FCG mice did not fully reflect
the behavior pattern we observed, with no consistent ef-
fects of testosterone on gene expression despite its potent
effect on anxiety-like behavior. We remain interested in
these genes due to our findings in the human postmortem
brain, but are searching for the node of the corticolimbic
network in which these sex-related factors might modu-
late behavior. Given our findings in humans on sex speci-
ficity of GABA, SST, and BDNF deficiency in the
amygdala, along with our previous studies on our genes of
interest in the frontal cortex of stressed mice, here we
chose to examine the amygdala in FCG mice of different
ages (adults and pre-pubertal) and stress conditions (non-
stressed and chronically stressed) to expand our under-
standing of how expression of these genes changes during
development and under varying stress conditions. Our
findings indicate that sex chromosome complement has
significant effects on expression of GABA- and BDNF-
related genes in weanling and adult stressed mice. Add-
itionally, by focusing our studies on the amygdala, we have
revealed a pattern of Sst gene expression that reflects the
opposing effects of sex chromosome complement and tes-
tosterone on anxiety-like behavior. Specifically, XY mice
exhibited both lower Sst expression and higher anxiety-
like behavior compared to XX mice, while testosterone-
treated mice had both higher Sst expression and lower
anxiety-like behavior compared to blank-treated mice.
Methods
Mice
The FCG mice used in these studies (originating from
Jackson Laboratories, Bar Harbor, ME, USA; B6.Cg-
Tg(Sry)2Ei Srydl1Rlb/Arnoj) were generated by crossing a
C57BL/6J female with an XY−Sry male (Y− indicates the ab-
sence of Sry on the Y chromosome, with Sry present instead
as an autosomal transgene; XYM). This cross yielded four
groups of mice: XXSry males (XXM), XX females (XXF),
XY−Sry males (XYM), and XY− females (XYF). These four
genotypes, with gonadal sex determination decoupled from
sex chromosome complement, allow us to investigate the
effects of sex chromosome complement and developmental
gonadal sex (i.e., organizational effects of hormones) inde-
pendently. The addition of a testosterone or blank capsule
(discussed below) after gonadectomy in adulthood also
allows us to investigate the effects of circulating hormones
(i.e., activational effects of testosterone). The mice were
maintained under standard conditions (12/12 h light/dark
cycle; 22 ± 1°C, food and water ad libitum), in accordance
with the University of Pittsburgh Institutional Animal Care
and Use Committee.
Experimental design
Cohort 1 was comprised of FCG weanlings of each geno-
type [XXF (n = 22), XYF (n = 21), XXM (n = 21), and XYM
(n = 17)]. In graphs representing results in this cohort, we
show all four groups as well as graphs summarized by main
effects [XX (n = 43), XY (n = 38); F (n = 43), M (n = 38)].
Cohort 1 mice were sacrificed on postnatal day 21 (P21;
with day of birth designated as P0; Fig. 1a). At the time of
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sacrifice, weanlings were rapidly decapitated, the brains
were collected for gene expression studies, and bloods were
collected for testosterone assays (described below). Wean-
lings were neither exposed to stress nor did they receive a
circulating hormone manipulation.
Cohort 2 was comprised of non-stressed adult FCG
mice housed by gonadal sex and hormone treatment.
Additionally, all mice in cohort 2 (Fig. 1b) were gonad-
ectomized at 15 weeks to remove endogenous sources of
gonadal hormones; at the time of gonadectomy, half of
each genotype was implanted with a subcutaneous
testosterone (T)-filled capsule, while the other half of
each genotype received a blank (B) capsule [XXF + B
(n = 11), XXF + T (n = 11), XYF + B (n = 11), XYF +
T (n = 10), XXM + B (n = 13), XXM + T (n = 16),
XYM + B (n = 13), and XYM + T (n = 11)]. In graphs
representing results in this cohort, we show all eight
groups as well as graphs summarized by main effects [XX
(n = 51), XY (n = 45); F (n = 43), M (n = 53); B (n = 48), T
(n = 48)]. Cohort 2 did not undergo a stress exposure and
was sacrificed at 24 weeks, at which time the brains and
bloods were collected.
Cohort 3 was comprised of adult FCG mice (housed
by gonadal sex and hormone treatment) that were ex-
posed to unpredictable chronic mild stress (UCMS). Co-
hort 3 (Fig. 1b) was gonadectomized at 15 weeks, and
half of each genotype was implanted with a subcutane-
ous T-filled capsule while the other half received a blank
capsule [XXF + B (n = 12), XXF + T (n = 18), XYF + B
(n = 13), XYF + T (n = 13), XXM + B (n = 18), XXM + T
(n = 13), XYM + B (n = 12), XYM + T (n = 13)]. In
graphs representing results in this cohort, we show all
eight groups as well as graphs summarized by main
effects [XX (n = 61), XY (n = 51); F (n = 56), M (n = 56);
B (n = 55), T (n = 57)]. After allowing 4 weeks for mice
to recover from surgery and for hormone levels to
equilibrate, cohort 3 was exposed to 8 weeks of UCMS
(details below). Mice were sacrificed at week 24 (while
still being exposed to stressors), and the brains and
bloods were collected. We previously reported behav-
ioral results and frontal cortex gene expression results
from this cohort [22, 29].
Adult hormone manipulations
Adult FCG mice (cohorts 2 and 3) were bilaterally
gonadectomized under isoflurane anesthesia in sterile
conditions at 15 weeks of age to remove endogenous
source of gonadal hormones. At the time of surgery, mice
were implanted with either a subcutaneous silastic (Dow
Corning Corp., Midland, MI, USA) capsule containing 5-
mm crystalline testosterone (1.57-mm ID× 2.41-mm OD),
or with a similarly sized blank capsule. This size testoster-
one capsule yields circulating testosterone levels at, or
slightly above, normal male levels [29]. At the time of
sacrifice, trunk blood was collected for testosterone assays
(see details below) to verify the efficacy of our adult
hormone manipulation.
Unpredictable chronic mild stress
Mice in cohort 3 were subjected to 8 weeks of UCMS, a
behavioral paradigm designed to increase behavioral
emotionality and elicit homologous features that are
associated with human depression; UCMS respects the
timeframe of onset and efficacy of antidepressant treat-
ment [30]. Group-housed mice (gonadal sex and hormone
treatment matched) were exposed to a randomized sched-
ule of environmental stressors 7 days a week, gradually
increasing in intensity, starting with 1–2 separate stressors
a day and ending with 4–5 stressors a day (separately and
in tandem with one another) during the final week.
Fig. 1 Experimental design for cohorts 1, 2, and 3. a Mice in cohort 1 were sacrificed at postnatal day 21 (P21; prior to the onset of puberty). b
Mice in cohorts 2 and 3 were gonadectomized (GDX) at ~15 weeks of age and implanted subcutaneously with either a testosterone (T)-filled or
blank capsule. After GDX, mice in cohort 2 were left unmanipulated until they were sacrificed at 24 weeks of age. After GDX, mice in cohort
3 were exposed to 8 weeks of unpredictable chronic mild stress (UCMS), and then sacrificed (same age as cohort 2). At the time of sacrifice for all
cohorts, the brains were harvested for gene expression analyses and bloods were collected for hormone assays
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Disturbances included light cycle disruption, tilted cage
(45° tilt), social stress (rotate mice into previously occu-
pied cages), reduced space (limiting mice to 1/3 of typical
space in cage), aversive smell (20 min of exposure to
bobcat or fox urine), no bedding or wet bedding over-
night, mild restraint (50-mL conical tube with air hole for
15 min), and forced bath (approximately 2 cm of water for
15–45 min). We assessed weight and fur weekly to track
progression of the UCMS syndrome.
Mouse sacrifice and blood collection
Cohort 1 mice (weanlings) were sacrificed by rapid decapi-
tation on postnatal day 21 just as they were weaned from
their mothers. The brains were dissected out and immedi-
ately flash frozen on dry ice. Trunk blood was collected
and allowed to clot at room temperature for 90 min, after
which it was spun down to separate the serum from the
plasma. The serum was subsequently used in the testos-
terone hormone assay.
Adult mice (cohorts 2 and 3) were sacrificed at 24 weeks
of age. Importantly, mice in cohorts 2 and 3 received the
same adult hormone manipulation (i.e., same timing of
gonadectomy, same testosterone manipulation, and same
amount of time between gonadectomy and sacrifice).
Adult mice were anesthetized by isoflurane and rapidly
decapitated. The brains were dissected out and immedi-
ately flash frozen on dry ice. Trunk blood was collected,
allowed to clot at room temperature for 90 min, and the
serum separated out to measure testosterone levels.
Testosterone assay
Circulating testosterone levels of cohort 1 (weanlings) and
cohort 2 (adult non-stressed) were measured using a
testosterone (mouse/rat) ELISA assay (IBL America;
Minneapolis, MN) in accordance with kit directions.
Circulating testosterone levels of cohort 3 (adult stressed)
were measured offsite with the same ELISA kit, and were
previously reported [29]. Importantly, mice treated with
testosterone did not differ in testosterone levels and had
significantly higher testosterone levels when compared to
blank-treated mice (reported below in Results). Addition-
ally, our measured testosterone levels in testosterone-
treated mice were within the range of a normal adult male
mouse when measured using the same ELISA kit (accord-
ing to kit product information). Any subjects that fell out-
side the range for their treatment group (as determined by
GraphPad Grubbs’ outlier test) were eliminated from
qPCR testing and analysis.
Processing of brain tissue: BLA dissection and gene
expression analyses
Bilateral micropunches (1-mm bore punch) of the BLA
(between Bregma −0.94 and −1.82 mm; [31]) were
obtained from approximately six 160-μm thick coronal
tissue sections cut on a cryostat. All tools were treated
with RNase Zap to eliminate any RNases. Punches were
stored in RNase free 1.5-mL tubes at −80°C prior to RNA
extraction. Total RNA was extracted from BLA tissue
punches using RNeasy Plus Kits (Qiagen; Valencia, CA,
USA). Cohort 1 (weanling) and cohort 3 (adult stressed)
RNA was extracted using RNeasy Plus Micro kits, while
cohort 2 (adult non-stressed) RNA was extracted using
RNeasy Plus Mini kits with Qiashredder. RNA from the
BLA for all cohorts was reverse-transcribed into comple-
mentary DNA (cDNA) using QScript cDNA Supermix
(olido(dT) and random primers (Quanta Biosciences,
Gaithersburg, MD, USA)). Small PCR products were
amplified on a MJ Research (Waltham, MA, USA) DNA
Engine Opticon System for qPCR using universal PCR
conditions (65 to 59 °C touch-down and 40 cycles (10 s at
95 °C, 10 s at 59 °C, and 10 s at 72 °C)). cDNA was ampli-
fied in 20-μL reactions (0.1 × SYBR Green, 3 mM MgCl2,
200 nM dNTPs, 200 nM primers, 0.25 unit Platinum Taq
DNA Polymerase (Invitrogen, Carlsbad, CA, USA)).
Samples were run in triplicate, and results were calculated
as the geometric mean of relative intensities compared to
three internal controls (actin, glyceraldehyde-3-phosphate
dehydrogenase, and cyclophilin). Notably, these internal
controls did not differ by sex-related factors, making them
acceptable housekeeping genes here. The results are
expressed as arbitrary signal (2−dCT × 10,000 [32]). Genes
of interest (Sst, Gad67, Gad65, TrkB, and Bdnf) were
selected based on our previous findings in the frontal cor-
tex of FCG mice [22, 29] as well as based on our human
postmortem findings [21, 22, 33]. Any gene expression
values that were statistical outliers based on Grubbs’ out-
lier test were excluded from qPCR analysis.
Heatmap visualization of gene expression results
In order to gain a broader representation of our gene
expression results, we created expression heatmaps
using matrix2png online software [34]. Expression for
each main sex-related factor was calculated by dividing
gene expression in the male phenotype by expression in
the female phenotype (sex chromosome complement:
XY/XX; organizational: testes during development/ovar-
ies during development; activational: testosterone/blank).
If expression of the gene was higher in the male phenotype,
the color in the heatmap is red; if expression was higher in
the female phenotype, the color in the heatmap is blue.
Correlation between gene expression and anxiety-like
behavior
Using Spearman correlation, we compared BLA expression
of each gene examined here (Sst, Gad67, Gad65, TrkB,
Bdnf) to anxiety-like behavior in the same cohort of
stressed mice (behavior reported separately in [22]). The
results from multiple anxiety-like behavior measures were
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combined into anxiety-like Z-scores to reduce the
complexity of the correlation analysis (details on Z-scores
reported in [29]). The anxiety-like behavior measures were
compiled from data generated in the elevated plus maze
(time in open arms and percent crosses into open arms)
and the open field test (time in the center and percent
distance traveled in the center). Z-scores calculate how
many standard deviations (σ) an observation (X) is above or




The first step is to calculate the Z-score for each behav-
ioral test measure (e.g., Z_EPM_PercentCrossesOpe-
nArms or Z_OF_PercentTimeCenter); this is performed
by normalizing an individual mouse’s test measure to the
mean and standard deviation of the comparison group.
For all Z-scores, we used XX blank mice as the compari-
son group. The directionality of the Z-score was adjusted
such that increased values represented increased anxiety-
like behavior (e.g., decreased time in the open arms of the
elevated plus maze was considered increased anxiety-like
behavior). We next calculated the Z-score for each mouse
per behavioral test by averaging the two individual Z-mea-
sures for each test (e.g., averaging Z_EPM_TimeOpe-
nArms and Z_EPM_PercentCrossesOpenArms to get
Z_EPM_Anxiety). Finally, the overall anxiety-like Z-score
was calculated by averaging the Z_EPM_Anxiety and
Z_OF_Anxiety scores. Correlations were performed
between the Z_Anxiety measure for each mouse and ex-
pression of each gene (for the entire stressed cohort, as well
as performed in groups based on main effects (XX vs. XY,
ovaries vs. testes, and blank vs. testosterone treatment)).
Statistical analysis
Gene expression data for cohort 1 (weanlings) was
analyzed using a two-way ANOVA (sex chromosome
complement × developmental gonadal sex). Hormone
treatment was not included in the ANOVA for cohort 1,
as these mice did not receive a hormone manipulation;
however, we correlated circulating testosterone levels
and gene expression in weanlings using Pearson’s correl-
ation to determine whether endogenous testosterone
levels correlated with expression of any gene. Gene ex-
pression data for cohorts 2 (adult non-stressed) and 3
(adult stressed) was analyzed using a three-way ANOVA
(sex chromosome complement × developmental gonadal
sex × hormone treatment). If the ANOVA was signifi-
cant for any main effect or interaction, we performed
planned comparisons using Tukey’s post hoc test. We
did not correct for multiple testing in these studies, as
we had a priori hypotheses for these genes to be altered
based on our findings in the frontal cortex of FCG mice
and in human postmortem brain tissue of patients with
MDD [21–24, 29]. Data are expressed as mean ± SEM,
and significance was set at p < 0.05.
Results
FCG weanlings (cohort 1)
Gonadally intact FCG mice (XXF, XXM, XYF, XYM) were
sacrificed at the time of weaning (P21, Fig. 1a); this time-
point was selected to precede the onset of puberty. We
then examined the effects of sex chromosome comple-
ment and gonadal sex (i.e., organizational effects of hor-
mones) on expression of several genes in the BLA. There
was a main effect of sex chromosome complement, with
XY mice having lower expression of Sst (p < 0.08; Fig. 2a),
Gad67 (p < 0.01; Fig. 2b), and Gad65 (p < 0.035; Fig. 2c),
as well as TrkB (p < 0.05; Fig. 2d) in the BLA compared to
XX mice. There was no effect of sex chromosome comple-
ment on Bdnf expression in the BLA (Fig. 2e, p > 0.1).
Compared to gonadal females, gonadal males showed no
significant difference in expression of Sst (Fig. 2a), Gad67
(Fig. 2b), Gad65 (Fig. 2c), TrkB (Fig. 2d), or Bdnf (Fig. 2e)
in the BLA (p > 0.3 for all comparisons). At the time of
sacrifice, we also collected blood serum to measure circu-
lating testosterone levels. Mice in cohort 1 did not receive
artificial hormone treatment, and did not differ in circulat-
ing testosterone levels among genotypes (XX 0.127 ng/
mL ± 0.008; XXSry 0.137 ng/mL ± 0.010; XY− 0.133 ng/
mL ± 0.010; XY−Sry 0.139 ng/mL ± 0.011; p > 0.4). Seven
subjects were eliminated due to testosterone levels outside
of the expected normal circulating hormone levels
(>0.25 ng/mL). All of these subjects were gonadally male
(5 XXM, 2 XYM). Even when these seven subjects were
included in the gene expression analyses, we found that
our results remained consistent (i.e., same genes were
significant and same genes were not significant; data not
shown), indicating that the circulating testosterone levels
did not have an effect on gene expression. Additionally,
there were no significant differences in circulating tes-
tosterone across sex chromosome complement (XX
0.131 ng/mL ± 0.04; XY 0.140 ng/mL ± 0.05; p > 0.3) or
gonadal sex (M 0.129 ng/mL ± 0.04; F 0.143 ng/mL ± 0.05;
p > 0.1) when the outliers were removed from analysis.
When the seven subjects were included, we found that
testosterone was significantly higher in gonadal males
than in gonadal females (p < 0.03); however, this is
expected considering that the eliminated subjects were all
gonadally male with slightly higher testosterone levels.
Importantly, these results confirm that testosterone levels
at P21 did not differ between XXM and XYM mice (XXM
0.137 ng/mL ± 0.01; XYM 0.139 ng/mL ± 0.011; p > 0.45).
Additionally, circulating testosterone did not correlate
with expression levels of any gene of interest (p > 0.5 for
all correlation analyses). Together, this suggests that any
difference in gene expression we might observe based on
gonadal sex in weanlings will be due to organizational
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effects of hormones rather than activational effects of
testosterone.
FCG non-stressed adults (cohort 2)
In cohort 2 (Fig. 1b), FCG mice were gonadectomized in
adulthood to allow typical gonadal hormone exposure
during critical periods of development. Thus, any signifi-
cant effects of gonadal sex here are indicative of
organizational effects of hormones during development.
At the time of gonadectomy, mice were given a hormone
replacement in the form of a blank- or testosterone-
filled capsule to examine the activational effects of circu-
lating testosterone. In cohort 2, mice treated with testos-
terone capsules did not differ in serum testosterone
levels (p > 0.1). Additionally, testosterone-treated cohort
2 mice had significantly higher testosterone levels com-
pared to blank-treated mice (blank 0.1425 ng/mL ±
0.0115; testosterone 2.802 ng/mL ± 0.1341; p < 0.001).
Mice were sacrificed 12 weeks after gonadectomy; mice
in cohort 2 were not exposed to chronic stress in adult-
hood (in contrast to cohort 3). We then examined main
effects of sex chromosome complement, gonadal sex,
and hormone treatment, along with any interactions
between main effects on BLA gene expression. We did
not observe a significant effect of sex chromosome com-
plement on Sst (Fig. 3a), Gad67 (Fig. 3b), Gad65 (Fig. 3c),
or Bdnf (Fig. 3e) expression in adult non-stressed mice
(p > 0.5 for all comparisons). However, similar to what
was observed in weanlings, adult non-stressed XY mice
had significantly lower expression of TrkB compared to
XX mice (p = 0.05, Fig. 3d). In contrast with what we
found in weanlings, we observed a significant effect of
developmental gonadal sex (i.e., organizational effect of
hormones) on Bdnf expression in the BLA (Fig. 3e).
Specifically, mice with testes during development had
significantly lower expression of Bdnf compared to mice
that had ovaries during development (p < 0.025). There
was no significant effect of developmental gonadal sex
on BLA expression of Sst (Fig. 3a), Gad67 (Fig. 3b),
Gad65 (Fig. 3c), or TrkB (Fig. 3d; p > 0.6 for all compari-
sons). There was also a significant activational effect of
testosterone on Bdnf expression, with testosterone-
Fig. 2 The effects of sex-related factors on expression of GABA- and
BDNF-related genes in the basolateral amygdala of weanling mice.
Mice with male sex chromosome complement (XY) had significantly
lower expression of Sst (a), Gad67 (b), Gad65 (c), and TrkB (d) compared
to XX mice; there was no effect of sex chromosome complement on
Bdnf expression (e). There were no organizational effects of hormones
on expression of any gene investigated (a–e). For each gene, graphs
on the left show results individually for all four experimental groups.
Graphs on the right summarize the same data as shown on the left
after collapsing across main effects. Numbers at base of bars indicate N.
For main effect comparisons: **p < 0.01; *p < 0.05; #p < 0.1. F gonadal
female, M gonadal male
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treated mice having higher BLA Bdnf expression than
blank-treated mice (p < 0.035, Fig. 3e). There was no
activational effect of testosterone on Sst (Fig. 3a), Gad67
(Fig. 3b), Gad65 (Fig. 3c), or TrkB (Fig. 3d; p > 0.3 for all
comparisons).
In addition to investigating the main effects in the non-
stressed adult cohort, we also found a number of interest-
ing interactions of main effects on BLA gene expression.
We found a significant gonadal sex by hormone interaction
for both Gad67 (p < 0.025, Fig. 4a) and Gad65 (p < 0.032,
Fig. 4b). Gad67 and Gad65 exhibited similar patterns of
gene expression, with testosterone having no effect on go-
nadal females but testosterone increased expression of both
genes in gonadal males (p < 0.05 for both genes). In another
exploratory analysis, we found that testosterone increased
Bdnf expression in gonadal females (p < 0.037), but had no
effect on Bdnf expression in gonadal males (p > 0.2; Fig. 4c).
FCG stressed adults (cohort 3)
In cohort 3, an additional set of FCG mice was gonadecto-
mized and given testosterone or blank capsules at 15-
week old (same age as non-stressed adults in cohort 2,
Fig. 1b). However, mice in cohort 3 were additionally sub-
jected to 8 weeks of UCMS to induce elevated anxiety-/
depressive-like behaviors. Compared to XX mice, XY mice
had significantly lower Sst expression (p < 0.04; Fig. 5a);
this pattern is similar to what we observed in weanlings
(Fig. 2a). There was no effect of sex chromosome comple-
ment on expression of Gad67 (Fig. 5b), Gad65 (Fig. 5c),
TrkB (Fig. 5d), or Bdnf (Fig. 5e) in the BLA (p > 0.1 for all
comparisons). Compared to mice with ovaries during
development, mice with testes during development
showed no significant differences in expression of Sst
(Fig. 5a), Gad67 (Fig. 5b), Gad65 (Fig. 5c), TrkB (Fig. 5d),
or Bdnf (Fig. 5e) in the BLA (p > 0.1 for all comparisons).
There was a main activational effect of testosterone
exposure on Sst, with testosterone increasing Sst expres-
sion (p < 0.033, Fig. 5a). Similar to what was observed in
cohort 2 (adult non-stressed), there was a main effect of
circulating testosterone on BLA Bdnf expression (p < 0.023,
Fig. 5e). Interestingly, however, this difference occurred in
the opposite direction as observed in the non-stressed
cohort (compare Figs. 3e and 5e), with testosterone de-
creasing BLA Bdnf expression in stressed mice. There were
no significant effects of testosterone on expression of
Gad67 (Fig. 5b), Gad65 (Fig. 5c), or TrkB (Fig. 5d) expres-
sion in the BLA (p > 0.2 for all comparisons).
We also investigated a number of interactions between
the main effects. We found a significant sex chromosome
complement by gonadal sex interaction for Sst expression
in the BLA (p < 0.037, Fig. 6a). We also found a trend for a
gonadal sex by hormone interaction on Bdnf expression
(p < 0.082; Fig. 6b). Exploratory follow-up analyses
revealed that testosterone treatment decreased Bdnf
Fig. 3 The effects of sex-related factors on expression of GABA- and
BDNF-related genes in the basolateral amygdala of non-stressed adult
mice. There was no effect of sex chromosome complement on
expression of Sst (a), Gad67 (b), Gad65 (c), or Bdnf (e). However, mice
with male sex chromosome complement (XY) had significantly lower
expression of TrkB (d). e Mice with male developmental gonadal sex had
lower Bdnf expression compared to mice with female developmental
gonadal sex. Testosterone significantly increased expression of Bdnf.
For each gene, graphs on the left show results individually for all eight
experimental groups. Graphs on the right summarize the same data as
shown on the left after collapsing across main effects. Numbers at the
base of bars indicate N. For main effect comparisons: *p< 0.05. T
testosterone, B blank, F gonadal female, M gonadal male
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expression in gonadal females (p < 0.01), but had no
effect on gonadal males (p > 0.1). Again, this difference
in Bdnf expression was the opposite of what was
observed in non-stressed mice in cohort 2 (compare
Figs. 4c and 6b). In contrast to what we observed in
cohort 2 (non-stressed adults), the interaction of gonadal
sex and testosterone treatment was not significant for
Gad67 or Gad65 (p > 0.1). However, the three-way inter-
action of sex chromosome complement, gonadal sex, and
testosterone treatment was significant for both Gad67
(p < 0.039, Fig. 5b, left) and Gad65 (p < 0.027, Fig. 5c,
left). Specifically, there was a significant gonadal sex
by hormone treatment interaction in XY, but not in
XX mice. When the data for Gad67 and Gad65 gene
expression is split by sex chromosome complement, it
becomes evident that the pattern of gene expression
observed in the non-stressed cohort (Fig. 4a, b) is
reflected in stressed XY mice, but not in stressed XX
mice. Specifically, the gonadal by hormone interaction
in stressed XY mice is significant for Gad67 (p < 0.05,
Fig. 5b, left) as well as Gad65 (p < 0.035, Fig. 5c, left),
while the gonadal by hormone interaction in XX mice
is not significant (p > 0.1).
Heatmap visualization of gene expression by main sex-
related factors
In order to summarize our gene expression results and
reveal patterns of influence for sex-related factors on BLA
gene expression, we visualized our results using heatmaps.
As was evident from the qPCR data, there was a pattern
for significantly lower expression of Sst, Gad67, Gad65,
and TrkB in XY weanling mice compared to XX weanling
mice (Fig. 7a). Similarly, this pattern was reflected in the
adult non-stressed cohort (Fig. 7b), although only statisti-
cally significant for TrkB. This pattern was not reflected
overall in the adult stressed mice (Fig. 7c), except for Sst
and Bdnf. The heatmap revealed different patterns of
expression when examining organizational effects of
hormones (i.e., gonadal) on gene expression. In weanlings,
with no significant differences between groups, we
observed a pattern for higher expression of Gad67 and
Gad65 in gonadal males, as well as a pattern for lower
expression of TrkB and Bdnf in gonadal males (Fig. 7a).
Interestingly, this pattern changed in the adult non-
stressed cohort to reflect lower expression for all genes in
mice with testes during development (Fig. 7b). This
general pattern was present in the adult stressed cohort as
well (Fig. 7c). Finally, we used the heatmaps to compare
activational effects of testosterone on expression of genes
in adult mice. There was no clear pattern of expression in
adult non-stressed mice across genes (Fig. 7b). However,
the heatmap for cohort 3 revealed that both Sst and Bdnf
had the opposite pattern of expression under stressed
conditions compared to non-stressed conditions. Sst now
showed significantly higher expression with testosterone
treatment while Bdnf showed significantly lower expres-
sion (Fig. 7c). Together, these results indicate complicated
balancing roles between sex-related factors, which differ
based on age and stress exposure.
Correlation between gene expression and anxiety-like
behavior
Refer to Table 1 for statistical information associated with
the correlation analysis. We first examined the data for
significant correlations between anxiety-like behavior and
gene expression in all mice subjected to UCMS. We did
not perform behavior testing in the weanling or adult
non-stressed cohorts, as we did not want these cohorts to
be exposed to the stress of behavior testing. We found
that Sst was negatively correlated with anxiety-like behav-
ior (p = 0.041) for the entire stressed cohort (i.e., higher
Sst expression levels were correlated with decreased
anxiety-like behavior). There was also a trend (p = 0.077)
for a positive correlation between Bdnf expression and
anxiety-like behavior for the entire stressed cohort (i.e.,
higher Bdnf expression levels were correlated with
increased anxiety-like behavior). There were no other
correlations between anxiety-like behavior and expression
Fig. 4 Interactions of sex-related factors on expression of GABA- and BDNF-related genes in the basolateral amygdala of non-stressed adult mice.
There was a significant gonadal sex by hormone interaction on expression of Gad67 (a) and Gad65 (b), with testosterone significantly increasing
gene expression only in gonadal males. c There was a significant gonadal sex by hormone interaction for Bdnf, with testosterone significantly
increasing expression only in gonadal females. Numbers at the base of bars indicate N. For post hoc two-group comparisons: $p < 0.05. T
testosterone, B blank, F gonadal female, M gonadal male
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of the remaining genes (Gad67, Gad65, TrkB; p > 0.25 for
all comparisons) in the entire stressed cohort. We then
split the cohort into groups based on each main sex-
related factor (XX, XY, gonadal males, gonadal females,
blank-treated, testosterone-treated) and again performed
correlation analyses between gene expression and anxiety-
like behavior. We found a trend for Sst to be negatively
correlated with anxiety-like behavior in gonadal males
(p = 0.089), with higher Sst expression levels being corre-
lated with decreased anxiety-like behavior. We also found
a positive correlation between Bdnf expression and
anxiety-like behavior (p = 0.02) in XY mice and a trend
(p = 0.058) in gonadal females (i.e., higher Bdnf expression
levels were correlated with increased anxiety-like behavior).
We found no other correlations between gene expression
and anxiety-like behavior when the cohort was split by
main sex-related variables (p > 0.1 for all comparisons).
Discussion
Through examination of gene expression in the BLA of
FCG mice at multiple developmental time-points and
under different stress conditions, we were able to reveal
several sex-based differences in expression of GABA-
related and BDNF-related genes. In weanlings (Fig. 2),
sex chromosome complement significantly influenced
expression of Sst, Gad67, Gad65, and TrkB, with lower
expression of these genes in XY compared to XX mice.
Gonadal sex and circulating testosterone did not
influence expression of these genes in weanlings. In
non-stressed adult mice (Fig. 3), TrkB continued to be
significantly different based on sex chromosome comple-
ment (XX > XY). Bdnf expression was also influenced by
sex-related factors in non-stressed adult mice, with
opposing effects of developmental gonadal sex (gonadal
female > gonadal male) and male-like testosterone levels
(blank < testosterone). Organizational and activational
Fig. 5 The effects of sex-related factors on expression of GABA- and
BDNF-related genes in the basolateral amygdala of stressed adult mice.
a Mice with male sex chromosome complement (XY) had lower
expression of Sst. Additionally, mice treated with testosterone had
higher Sst expression. There were no main effects of sex chromosome
complement on expression of Gad67 (b), Gad65 (c), TrkB (d), or Bdnf (e).
There were no main effects of gonadal sex on gene expression (a–e).
Testosterone significantly decreased expression of Bdnf (e), but did
not affect expression of Gad67 (b), Gad65 (c), or TrkB (d). There was a
significant three-way sex chromosome complement × gonadal sex ×
hormone interaction on expression of Gad67 (b, left) and Gad65 (c, left).
Specifically, the post hoc analyses revealed a significant interaction of
gonadal sex and hormone only in XY mice. Graphs on the left show
results individually for all eight experimental groups. For each gene,
graphs on the right summarize the same data as shown on the left
after collapsing across main effects. Numbers at the base of the bars
indicate N. For main effect comparisons: *p < 0.05. For interaction
between gonadal sex and hormone: δp < 0.05. T testosterone, B blank,
F gonadal female, M gonadal male
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hormone interactions for Gad67, Gad65, and Bdnf high-
light the distinct role that circulating hormones such as
testosterone play depending on gonadal sex. In stressed
adult mice (Fig. 5), we found opposing effects of sex
chromosome complement (XX > XY) and male-like
testosterone levels (blank < testosterone) on Sst expres-
sion in the BLA. Bdnf expression continued to be
affected by hormone treatment in adult stressed mice,
but the effect was opposite to what we observed in non-
stressed adults (blank > testosterone).
Exposure to stress and trauma during adolescence can
have long-term effects on neural transmission and disease
vulnerability. Given this, the implications of our weanling
results are especially of interest to us. The development of
the GABA system in particular has many long-term
effects on the structure and communication of the cortex
as a whole. GABA initially begins as an excitatory neuro-
transmitter following birth, but continues to develop
during the pre-pubertal stages and becomes inhibitory
(reviewed in [35]). This transition is significant, as it
contributes to synaptic development that occurs during
puberty and adulthood. As the GABA system de-
velops during adolescence, it also contributes to the
synchronization of cortical activity (reviewed in [36]).
Dysregulation of cortical synchronization is thought
to be a possible contributor to the development of
MDD, with increased synchronization of neuron firing
observed in subjects with the disorder [37]. Differences in
GABA function between males and females during adoles-
cence may influence sex-specific synaptic development or
cortical synchronization later in life, subsequently affect-
ing cortical development and vulnerability for psychiatric
diseases such as MDD. Here, we found that weanling mice
with XY sex chromosome complement had lower GABA-
related gene expression compared to mice with XX sex
chromosome complement. Given that adult XY mice
Fig. 6 Interactions of sex-related factors on expression of GABA- and BDNF-related genes in the basolateral amygdala of stressed adult mice.
a There was a significant sex chromosome complement by gonadal sex interaction for Sst, with a pattern for an increase in expression in gonadal
males compared to gonadal females for XX mice and a pattern of a decrease in expression in gonadal males compared to gonadal females for
XY mice. b There was a trend for an interaction of gonadal sex and hormone on Bdnf expression, with exploratory analysis revealing that
testosterone decreased Bdnf expression only in gonadal females. Numbers at the base of the bars indicate N. For post hoc two-group
comparisons: $$p < 0.01. T testosterone, B blank, F gonadal female, M gonadal male
Fig. 7 Heatmap representation of basolateral amygdala gene
expression results. Expression for each main factor is expressed as
the “male” phenotype divided by the “female” phenotype (i.e., sex
chromosome complement, XY/XX; organizational, male gonads/female
gonads; activational, testosterone/blank). Red is indicative of higher
levels of expression in male phenotypes; blue is indicative of higher
levels of expression in female phenotypes. Heatmap representation
was done for a weanlings, b adult non-stressed, and c adult stressed.
For main effect comparisons: **p < 0.01; *p < 0.05; #p < 0.1
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show elevated anxiety-like behavior in adulthood [22], this
pre-pubertal difference in GABA-related gene expression
may contribute to adult anxiety-/depressive-like behavior.
Differences in GABA-related gene expression based on sex
chromosome complement in weanlings could permanently
affect the way the brain communicates by affecting how
neurons signal one another and are synchronized in adult-
hood. Perhaps more importantly, the pre-pubertal results
emphasize that early amygdala development differs signifi-
cantly by sex chromosome complement and deserves more
attention given the long-lasting effects these GABA differ-
ences could have, with potentially different developmental
trajectories in XY and XX mice.
The lack of organizational effects of hormones in
weanlings becomes more interesting when examined
within the context of all three tested cohorts. Since we
observed sex differences in gene expression due to
organizational effects of hormones in both of our adult
cohorts, while not observing any sex differences in our
pre-pubertal mice, this suggests that the observed sex
differences are due to effects of hormones from the go-
nads during puberty. This holds important implications
for understanding the role gonads during puberty play
in affecting not only behavior (as reviewed in [38]) but
also in the development of the cortex (as reviewed in
[38],[39]). Since these sex differences in gene expression
are observed in our adult cohorts, this further suggests
that these organizational effects that occur during
puberty drive permanent effects on gene expression in
the BLA. This finding is also interesting since puberty is
the developmental time-point when the sex difference in
depression incidence emerges (e.g., [40–44]).
Although we did not compare our non-stressed and
stressed cohorts directly within the same experiment, we
did find distinct patterns of gene expression within each
stress exposure. Some patterns of gene expression only
Table 1 Correlation between basolateral amygdala gene expression and anxiety-like
behavior








Correlation with anxiety-like 
behavior in XX mice
Correlation with anxiety-like 
behavior in XY mice
Rho p-value Rho
Sst -0.139 0.146 -0.180 0.108
Gad67 -0.039 0.384 -0.075 0.302
Gad65 -0.032 0.404 -0.003 0.491
Trkb -0.087 0.255 0.001 0.496
Bdnf 0.027 0.421 0.299 0.020
Correlation with anxiety-like 
behavior in gonadal females
Correlation with anxiety-like behavior
In gonadal males
Rho Rho
Sst -0.152 0.134 -0.188 0.089
Gad67 0.033 0.404 -0.154 0.133
Gad65 0.014 0.459 -0.083 0.276
Trkb -0.027 0.421 -0.017 0.452
Bdnf 0.223 0.058 0.006 0.484
Correlation with anxiety-like 
behavior in blank-treated mice
Correlation with anxiety-like behavior 
in testosterone-treated mice
Rho Rho
Sst -0.071 0.308 -0.101 0.229
Gad67 0.010 0.471 0.016 0.452
Gad65 0.007 0.479 0.064 0.319
Trkb -0.144 0.149 -0.050 0.357








Gray shades indicate significant correlations (p < 0.05)
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emerged when adult mice were exposed to stress. For
instance, the opposing effects of male sex chromosome
complement and testosterone on Sst expression (i.e., lower
Sst expression in XY mice, but higher expression in mice
treated with testosterone) only emerged under stressed
conditions. Similarly, testosterone had an opposite effect
on Bdnf expression based on whether the mice were
chronically stressed or not, with testosterone increasing
Bdnf expression under non-stressed conditions, but
decreasing expression under chronic stress conditions.
Likewise, some sex-related effects are masked under
chronic stress conditions. For instance, the effect of sex
chromosome complement on TrkB disappears under
chronic stress conditions, along with the organizational
effect on Bdnf expression. With these changes in patterns
of gene expression, we can begin to construct our inter-
pretation of the GABA and BDNF systems function under
no stress and chronically stressed conditions.
Here, we found that XX mice had higher TrkB expres-
sion compared to XY mice in weanlings as well as in non-
stressed adults. Interestingly, this difference based on sex
chromosome complement did not persist under adult
stressed conditions. Previously, we found that frontal cor-
tex TrkB expression was negatively correlated with
anxiety-like behavior [29]. This evidence supports a poten-
tial underlying XY vulnerability for MDD that is reflected
in changes to the BDNF system. In addition to the
changes observed in TrkB, Bdnf also shows changes in its
pattern of expression due to sex-related factors. Interest-
ingly, these differences are dependent on stress exposure.
Specifically, we found that testosterone increased Bdnf
expression in non-stressed gonadal females, but decreased
Bdnf expression in stressed gonadal females. Another
study found higher Bdnf expression in the BLA of gonad-
ally intact adult male mice compared to female mice [45].
Here, we observed an increase in Bdnf expression in non-
stressed mice treated with testosterone, even in those that
were gonadally female. This suggests that the sex differ-
ence in BLA Bdnf expression reported in [45] may be due
to circulating testosterone, as opposed to organizational
effects of hormones or sex chromosome complement. It is
important to emphasize that this is an example of how
circulating hormones can affect gene expression differ-
ently depending on stress conditions, and also depending
on other sex-related factors. Overall, these changes to the
Bdnf system hold important implications about neural
communication in the brain. As Bdnf works largely to
maintain levels of neuronal excitation through inhibition
of GABA signaling, decreases in Bdnf or TrkB may
contribute to an increase in GABA inhibitory signaling.
Moreover, testosterone decreased both anxiety-like behav-
ior and Bdnf expression in stressed mice, and there was a
trend for a positive correlation between Bdnf expression
and anxiety-like behavior. Together, this suggests that the
anti-anxiety effects of testosterone might be mediated by
changes in Bdnf. When we split the cohort into groups
based on sex-related factors, the positive correlation
between anxiety-like behavior and Bdnf expression was
found in XY mice and in gonadal females only, suggesting
that the effects of Bdnf expression on anxiety-like behavior
are more salient in XY mice and in gonadal females.
Gad67 and Gad65 consistently show the same expres-
sion patterns within each experimental condition. This
provides further support that the two are co-regulated/co-
expressed and behave similarly under a variety of stress
and age conditions, as well as with various sex-related
factors. It is important to note, however, that within each
age or stress exposure, the sex-related factors affected
Gad67 and Gad65 expression differently. For instance,
there was a significant interaction between gonadal sex
and testosterone treatment on Gad67 and Gad65 expres-
sion in non-stressed adults, but a significant three-way
interaction between sex chromosome complement, go-
nadal sex, and testosterone in stressed adults. Specifically,
the interaction between gonadal sex and testosterone is
reflected only in XY mice under stressed conditions. It is
possible that stress exposure exacerbates changes in the
GABA system only in XY mice. Since we observed an
effect of sex chromosome complement on Gad67 and
Gad65 expression pre-pubertally and in stressed adults,
but not in non-stressed adults, this suggests a possible
difference in the pre-pubertal condition that is only
revealed again in adulthood when an animal is stressed.
We previously found that mice with XY sex chromo-
some complement had lower Sst expression in the
frontal cortex along with higher anxiety-like behavior
compared to XX mice [22]. However, in the frontal
cortex, testosterone did not influence Sst expression,
despite the potent effect of testosterone to decrease
anxiety-like behavior. The pattern of Sst gene expression
we observed in the BLA (lower Sst levels in XY mice,
with testosterone increasing Sst expression) is consistent
with the previous behavior results. Specifically, lower Sst
expression in the BLA with XY sex chromosome com-
plement is accompanied by higher anxiety-like behavior,
while an increase in Sst expression with testosterone is
accompanied by a decrease in anxiety-like behavior.
Further, our correlation analysis revealed a significant
negative correlation between Sst expression and anxiety-
like behavior (i.e., higher Sst expression was correlated
with decreased anxiety-like behavior). When split by
main sex-related factors, we found a trend for a negative
correlation only in gonadal males, seeming to imply that
developmental gonadal sex may have important effects
on changes in Sst along with behavior. Having previously
found SST to be reduced in the sgACC and DLPFC of
both males and females with MDD, but only in females
with MDD in the BLA, it follows that SST action in the
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BLA may be contributing to female vulnerability to
MDD. Our results here also show that Sst expression is
increased by testosterone, which also decreases anxiety-
like behavior. Given that females do not typically have
high levels of circulating testosterone, this may be influ-
encing amygdala SST levels in females, also potentially
contributing to female MDD vulnerability.
Our results for Sst suggest that sex chromosome comple-
ment and testosterone may be having conflicting actions on
BLA gene expression to modulate behavior. This “compen-
sation” phenomena has been described in the literature,
with the effects of male sex chromosome complement
counteracting effects of testosterone (or vice versa), serving
to decrease male-female differences [46]. Other studies
have found similar patterns of results. For instance, while
testosterone increases male sex behavior, XY mice exhibit
lower male sex behavior compared to XX mice [47].
Our results indicating that testosterone both decreases
anxiety-like behavior [22] and increases expression of
GABA-related genes in the BLA are consistent with find-
ings in both humans and rodents. For instance, XY humans
with complete androgen insensitivity syndrome exhibit
elevated levels of mood disorders [48–52], suggesting a
protective role for testosterone related to mood. Addition-
ally, low testosterone in human males is associated with
higher anxiety, and testosterone treatment results in
reduced anxiety in these men [53, 54]. Several studies in
rodents report similar anti-anxiety effects of testosterone.
For instance, rats with the testicular feminization mutation
(Tfm) of the androgen receptor exhibit higher anxiety-like
behaviors compared to wild-type males and females [55].
Additionally, mice with either a spontaneous or induced
Tfm of the androgen receptor have higher anxiety-like
behavior than wild-type mice [56, 57]. Our findings here
for effects of testosterone on expression of GABA- and
BDNF-related genes suggest that the anti-anxiety effects of
testosterone reported previously may be mediated by ex-
pression of these mood-related genes.
There are limitations of our study that are important to
highlight. First, the FCG mice that we conduct our studies
with are an artificial system that does not completely
match sex-related phenotypes in “normal” wild-type mice.
However, the use of the FCG mice are necessary to dissect
the sex-related factors that underlie the sex differences
observed in wild-type mice and humans. Also, it is
possible that testosterone levels may vary by sex chromo-
some complement during development. Although we do
not know that testosterone levels were equivalent at every
developmental time point in our mice, we did find that
they did not vary by sex chromosome complement at the
time of sacrifice for weanlings or adults (see Results). This
is especially important to note for the weanling mice,
as this confirms that during this organizational window
of development, testosterone levels did not vary by sex
chromosome complement (see Results). We intentionally
selected testosterone as our hormone treatment since
it can be converted into estradiol in the brain, and
subsequently have action at both estrogen and andro-
gen receptors. However, by doing this, we are not
able to discern which of these receptors might be
driving the observed effects of testosterone in the
current study. We will need to investigate receptor
specificity in future studies. As noted earlier, we were
also limited given that we did not directly compare
our non-stressed and chronically stressed groups
within the same experiment. Our use of tissue hom-
ogenate of the BLA masks any cell type specific
changes that may be occurring. In order to identify
these changes, we will have to change tactics moving
forward, potentially by using laser microdissection of
specific cell types prior to gene expression analyses.
Conclusions
Our results highlight sex chromosome complement as
being an important factor for modulating mood-related
genes, especially during pre-pubertal development. Given
the observation of organizational effects of hormones in
our adult cohorts, which were not found in our pre-
pubertal cohorts, our findings suggest that pubertal
hormones have an organizing effect on gene expression in
the BLA. Additionally, testosterone had different effects in
non-stressed vs. chronically stressed conditions based on
gonadal sex and, occasionally, sex chromosome comple-
ment. Sex differences in the BLA under stressed
conditions (especially when compared to the fewer sex
differences observed under non-stressed conditions)
suggest different molecular profiles in males compared
to females with MDD. SST modulation in the BLA in
particular may be key to understanding an underlying
mechanism for anxiety and female vulnerability to
MDD. The Sst results, in conjunction with our previous
behavioral findings, strongly suggest that although there
is an underlying vulnerability with XY sex chromosome
complement, circulating testosterone usually compen-
sates for this effect in typical males. Without these “pro-
tective” levels of circulating testosterone, women might
have lower amygdala SST expression, resulting in higher
MDD vulnerability.
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